explore -WSS

explore

author：entertainment 2025-09-29 16:46:05 - browse：2

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Biotech companies concerned about China biosecurity crackdown

WSS

How to address the problem of discarded donor organs

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Influencer to be charged after chaos erupts in New York City's Union Square

FDA does about

In search for therapies for solid tumors, companies turn to claudin

Clinical trials giant ICON acquires HumanFirst

focus

explore

Wikipedia

Apple is now the first public company to be valued at $3 trillion

Nearly two

Trump demands the U.S. pay no more for drugs than other countries … again

In search for therapies for solid tumors, companies turn to claudin

Peter Hotez and the public health issue of online harassment

Clinical trials giant ICON acquires HumanFirst

How one medical school became remarkably diverse

Congress gives doctors Medicare pay bump

Medical records are filled with copy

Pfizer highlights cancer drugs it thinks could reignite investor interest

leisure time

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

White House drug shortage group privately met with industry

Stem cell clinics for heart failure: buyer be wary

What Mike Pence has said that could be used in a Donald Trump trial

leisure time

focus

focus

knowledge